Código QR (código de barras bidimensional)

Combination therapy with lansoprazole and cholecalciferol is associated with a slower decline in residual beta-cell function and lower insulin requirements in children with recent onset type 1 diabetes: results of a pilot study

Abstract Objective To investigate the effects of combination therapy with cholecalciferol and lansoprazole on residual β-cell function and glycemic control in children with new-onset type 1 diabetes. Methods Children aged 6-12 years with type 1 diabetes were allocated to receive cholecalciferol an...

ver descrição completa

Na minha lista:
Principais autores: Raghunatha Reddy, Devi Dayal, Naresh Sachdeva, Savita Verma Attri, Vinod Kumar Gupta
Formato: Artigo
Idioma:Inglês
Publicado em: Instituto Israelita de Ensino e Pesquisa Albert Einstein 2022-11-01
coleção:Einstein (São Paulo)
Assuntos:
Diabetes mellitus
type 1
Blood glucose
Glycated hemoglobin A
Fasting
C-peptide
Drug tapering
Glycemic control
Cholecalciferol
Lansoprazole
Acesso em linha:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082022000100282&tlng=en
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados